New checkpoint inhibitor shows promise in clinical trial for non-Hodgkin’s lymphoma
A novel antibody plus rituximab can block the “don’t eat me” signal, enabling macrophages to devour cancer cells.
Dreams do come true after advanced care for lymphoma
Elaine Johnson of New Lenox wanted to beat cancer and spend more time at "the happiest place on earth." The cancer specialists at UChicago Medicine's Comprehensive Cancer Center at Silver Cross Hospital helped her realize her dream.
Immunotherapy: Why don't more patients respond?
Most physicians have been thrilled by the unprecedented success of the new treatments for some patients. Medical oncologist Thomas Gajewski, MD, PhD, and his team — early adopters— have been frustrated. They are focused on the failures.
